DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Deoxythymidine is an investigational drug.
There have been 8 clinical trials for Deoxythymidine. The most recent clinical trial was a Phase 2 trial.
The most common disease conditions in clinical trials are HIV Infections, Infection, and Communicable Diseases. The leading clinical trial sponsors are National Institute of Allergy and Infectious Diseases (NIAID), Bristol-Myers Squibb, and Vall d'Hebron Research Institute.
Recent Clinical Trials for Deoxythymidine
|An Open-Label Study of Continuation Treatment With Combination Pyrimidine Nucleosides in Patients With TK2||Modis Therapeutics, Inc.||Phase 2|
|Treatment of TK2 Deficiency With Thymidine and Deoxycytidine||Centro de Investigación Biomédica en Red Enfermedades Raras (CIBERER), Spain||Phase 1/Phase 2|
|Treatment of TK2 Deficiency With Thymidine and Deoxycytidine||Hospital Universitario 12 de Octubre||Phase 1/Phase 2|